Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
General21 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
General22 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
General11 hours agoWallaroos fall to Black Ferns 37-12 in Wellington Test
-
Noosa News23 hours agoRaising your voice | Noosa Today